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Abstract
Background: The gene PPARGC1A, in particular the Gly482Ser variant (rs8192678), had been proposed to be subject
to natural selection, particularly in recent progenitors of extant Polynesian populations. Reasons include high levels
of population differentiation and increased frequencies of the derived type 2 diabetes (T2D) risk 482Ser allele, and
association with body mass index (BMI) in a small Tongan population. However, no direct statistical tests for
selection have been applied.
Methods: Using a range of Polynesian populations (Tongan, Māori, Samoan) we re-examined evidence for
association between Gly482Ser with T2D and BMI as well as gout. Using also Asian, European, and African 1000
Genome Project samples a range of statistical tests for selection (FST, integrated haplotype score (iHS), cross
population extended haplotype homozygosity (XP-EHH), Tajima’s D and Fay and Wu’s H) were conducted on the
PPARGC1A locus.
Results: No statistically significant evidence for association between Gly482Ser and any of BMI, T2D or gout was
found. Population differentiation (FST) was smallest between Asian and Pacific populations (New Zealand Māori ≤ 0.
35, Samoan≤ 0.20). When compared to European (New Zealand Māori ≤ 0.40, Samoan ≤ 0.25) or African
populations (New Zealand Māori ≤ 0.80, Samoan≤ 0.66) this differentiation was larger. We did not find any strong
evidence for departure from neutral evolution at this locus when applying any of the other statistical tests for
selection. However, using the same analytical methods, we found evidence for selection in specific populations at
previously identified loci, indicating that lack of selection was the most likely explanation for the lack of evidence of
selection in PPARGC1A.
Conclusion: We conclude that there is no compelling evidence for selection at this locus, and that this gene
should not be considered a candidate thrifty gene locus in Pacific populations. High levels of population
differentiation at this locus and the reported absence of the derived 482Ser allele in some Melanesian populations,
can alternatively be explained by multiple out-of-Africa migrations by ancestral progenitors, and subsequent
genetic drift during colonisation of Polynesia. Intermediate 482Ser allele frequencies in extant Western Polynesian
populations could therefore be due to recent admixture with Melanesian progenitors.
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Background
The thrifty gene theory is based on the hypothesis that al-
leles causing increased weight, insulin resistance and type
2 diabetes (T2D) in contemporary populations were an
adaptation to fluctuating food availability [1], for example
from extreme environmental events and extended sea
travel, in ancestral populations. Any genuine thrifty gene
variant would have been selectively advantageous and
therefore subject to selection during human evolution.
Thrifty genetic variants arising early in hominid evolution,
for example the uricase knockout [2], would be expected
to be monomorphic and shared by all human populations.
However, candidate thrifty variants arising more recently
in human evolution and polymorphic in contemporary
populations should exhibit signatures of selection in the
immediate genomic vicinity.
The PPARGC1A transcriptional regulator has a central
role in insulin signalling and mitochondrial regulation [3].
The functional Gly482Ser (rs8192678) variant (reviewed
in [4]) in the PPARGC1A gene is associated with body
mass index (BMI) in a Tongan (Polynesian) population
[4]. This led to the hypothesis that the Gly482Ser variant
represents a candidate ‘thrifty variant’ in Pacific populations.
This was based largely on the observation that the postu-
lated thrifty (derived) 482Ser allele exhibited the highest
prevalence world-wide in Polynesian populations, who also
have high levels of T2D and BMI. In contrast, low T2D
prevalence levels have been recorded in Papuan populations
lacking the 482Ser allele [5]. This 482Ser allele observation
also supported by a previous report of extreme FST values (a
measure of inter-population difference at specific genetic
variants) at the PPARGC1A locus [5]. To date however, this
hypothesis has not been formally tested in a range of
Polynesian populations using more direct assessments of
natural selection.
The Māori and non-indigenous Polynesian populations
of Aotearoa New Zealand (NZ) have a high prevalence of
obesity, T2D and related metabolic conditions such as
gout [6–8]. The reasons for this appear to be complex and
are the result of a combination of poor environmental
dietary exposure (contributed to by socioeconomic status)
and inherited genetic variants [9]. However, extremely lit-
tle is known about the etiology of obesity and T2D in NZ
Māori and Pacific. If the PPARGC1A gene were associated
with weight and subject to selection in Pacific populations,
then this would be important knowledge on the aetiology
of these conditions in contemporary populations. Further-
more, evidence for selection during Polynesian population
history would aid in the destigmatisation of obesity. Here,
we tested for association between Gly482Ser rs8192678,
BMI, T2D and gout in several Polynesian populations. We
also examined evidence for recent positive selection at the
derived 482Ser allele and in the region of PPARGC1A, by
applying a recently developed analytical pipeline [10] to
genomic data from the various Polynesian and 1000
Genomes Project world-wide populations.
Methods
Populations
New Zealand (NZ) Māori, Cook Island Māori, Samoan,
Tongan and NZ Caucasian sample sets were examined
(Table 1). Samples were collected as part of the “Genetics
Table 1 Populations, genotyping platforms and analyses used to evaluate evidence of association and selection in PPARGC1A
Phenotype
Population Genotyping Platform Gout (n) Control (n) Analysis
NZ Caucasian TaqMan SNP Assay 647 360 Single Marker GLM + FST on rs8192678
NZ Māori TaqMan SNP Assay 137 176 Single Marker GLM + FST on rs8192678
CI Māori TaqMan SNP Assay 71 64 Single Marker GLM + FST on rs8192678
Samoan TaqMan SNP Assay 144 76 Single Marker GLM + FST on rs8192678
Tongan TaqMan SNP Assay 73 41 Single Marker GLM + FST on rs8192678
Māori AXIOM SNP chip 35 36 FST, Fay and Wu’s H, Tajima’s D, iHS and XP-EHH
Samoan OMNIexpress chip 48 48 FST, Fay and Wu’s H, Tajima’s D, iHS and XP-EHH
Unknown Phenotype
1KGP CEU WGS 99 FST, Fay and Wu’s H, Tajima’s D, iHS and XP-EHH
1KGP CHB WGS 103 FST, Fay and Wu’s H, Tajima’s D, iHS and XP-EHH
1KGP CHS WGS 108 FST, Fay and Wu’s H, Tajima’s D, iHS and XP-EHH
1KGP GBR WGS 92 FST, Fay and Wu’s H, Tajima’s D, iHS and XP-EHH
1KGP YRI WGS 109 FST, Fay and Wu’s H, Tajima’s D, iHS and XP-EHH
All individuals in the Māori AXIOM and Samoan OMNIexpress datasets were also genotyped by the TaqMan® assay, and included in their respective population
groups. NZ = New Zealand. CI = Cook Islands. WGS = whole genome sequencing. 1KGP = 1000 genomes project (http://www.1000genomes.org/home). Populations
used were Utah, USA residents with Northern and Western European ancestry (CEU, Han Chinese in Beijing, China (CHB), Southern Han Chinese (CHS), China,
British in England and Scotland (GBR) and Yoruba in Ibadan, Nigeria YRI. For a complete description of the 1000 Genomes project samples see http://
www.1000genomes.org/data#DataAvailable. No phenotypic data were available for these populations
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of Gout in Aotearoa” case–control study [11] and ethical
approval was obtained from the New Zealand Multi-
region Ethics committee (MEC/105/10/130). Each partici-
pant provided informed written consent. Patients with
gout satisfied, by clinical examination, the American
Rheumatism Association preliminary criteria for acute
gout [12]. BMI and self-reported T2D status was recorded
at time of recruitment. Subjects were classified into
ancestry groups based on self-reported ancestry of grand-
parents. Table 1 provides the number of samples in each
population, and the methods used for genotyping and data
analyses. Tables 2 and 3 describe clinical data and ancestry
information for the NZ sample sets.
Five additional populations were obtained from the
1000 Genomes Project phase 3 data release (see [13]):
two Asian populations: Han Chinese in Beijing, China
(CHB), Southern Han Chinese, China (CHS); two of
European ancestry: British in England and Scotland
(GBR) and Utah residents with Northern and Western
European ancestry (CEU); and one of African ancestry:
Yoruba in Ibadan, Nigeria (YRI). The CHB and CHS
populations are intermediate with regard to Gly482Ser
frequencies between the African (YRI) and European
(GBR, CEU) on the one hand and the Polynesian popu-
lations on the other [14].
Genotypic data
Two genotypic data sets were used for this study: (a) a
SNP-specific assay corresponding to a Glycine (C allele)
-Serine (T allele) substitution at amino acid position 482
in the PPARGC1A gene (dbSNP ID rs8192678 residing
on chromosome 4 (GRCh37 chr4:23815662) and geno-
typed on a subset of the above populations (see Table 1);
and (b) chromosome 4-wide genotypic data. For (a) SNP
rs8192678 was genotyped with TaqMan® assay ID
C___1643192_20 (Life Technologies, Carlsbad, CA)
using a LightCycler 480 Real-Time PCR System (Roche
Applied Science, Indianapolis, IN). The MINI MELT
program was run from within the LightCycler software,
and genotypes were assigned based on clustering within
the software. Clusters were visually checked with misas-
signed genotypes corrected where appropriate or desig-
nated as unknown. 9% of samples were re-genotyped
and cross checked as a quality control measure. All re-
genotyped samples had complete agreement with the
original genotypes. For (b) genotypic data for whole
chromosome analyses were obtained either directly from
SNP microarrays or whole genome sequencing. For the
SNP microarrays, 71 individuals who self-reported four
Māori grandparents were genotyped using an Affymetrix
AXIOM genome-wide ASI array (Table 1). Similarly, 96
individuals self-reporting four Samoan grandparents
were genotyped with an Illumina Human OmniExpress
bead chip. The individuals genotyped by SNP microarray
were a subset from those genotyped with the Taqman®
assay. Whole genome sequence (WGS) from 1000
Genomes Project phase 3 data release (via [13]) was used.
Association analyses
To determine associations between BMI and rs8192678
genotype, single marker linear regressions were under-
taken using the R statistical software environment [15].
Hardy-Weinberg equilibrium exact tests were calculated
using the R package HardyWeinberg [16]. For each
population, three modes of gene action were tested:
additive, dominant (both C and derived T allele), and
over-dominant. Age, sex, gout affection status, T2D, and
Structure-estimated ancestry proportions (calculated as
described in [11]) were included as covariates for BMI.
For T2D and gout affection status, logistic regression
was performed with the same covariates. A meta-
analysis of the Polynesian populations was undertaken
by combining the NZ Māori, Cook Island Māori,
Tongan and Samoan populations and repeating the
marker trait regressions as described above with the
added covariate of population.
Selection analyses
Pairwise FST [17] was estimated for all populations for
rs8192678. For populations where genome-wide geno-
typic data were available (i.e., the 1000 Genomes Project
and Axiom/Omni-genotyped populations, Table 1), the
following statistics were calculated: FST between sample
sets, Tajima’s D, Fay and Wu’s H, and integrated haplo-
type score (iHS, [18]) for individual populations, and
cross population haplotype homozygosity (XP-EHH,
[19]) to estimate selection between populations. To cal-
culate these statistics we used a customized analytical
pipeline [10]. For these analyses we assumed that the
482Ser allele was the derived allele, based on low fre-
quencies of this allele in African populations [5]. FST
was calculated for the entire chromosome using the
Weir and Cockerham method with negative values
manually set to zero [17]. Quantiles of 2.5 and 97.5%
were used to find the most extreme 5% of values.
Tajima’s D [20] and Fay and Wu’s H [21] were calculated
for the whole chromosome using bins of 1, 5 and 30
kbp. The Tajima’s D for the entire chromosome with
thresholds of the 2.5 and 97.5% quantiles used to estab-
lish the most extreme 5% of values.
The software package selscan [22] was used to calcu-
late iHS and XP-EHH with values for both being nor-
malised in frequency bins genome-wide. Cross
population extended haplotype homozygosity was used
to detect selection of alleles at or near fixation, and was
calculated between populations as described in [19]. An
iHS or XP-EHH absolute value of greater than 3.29 was
used as a threshold to estimate the most extreme 1% of
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Table 2 Clinical and genetic information for sample sets used for association analysis with BMI, T2D and gout
obs missing
(n)
NZ Caucasian obs missing
(n)
NZ Māori obs missing
(n)





Individuals - 1007 - 322 - 136 - 223 - 114
Gout (%) - 64.3 9 42.5 1 52.2 3 64.6 - 64.0
Diabetes (%) 10 11.5 11 42.8 4 26.5 6 14.3 3 18.4
Mean age (range) - 59.7 (18–94) 1 50.9 (17–82) - 52.4 (18–88) - 44.3 (17–71) - 42.8 (18–79)
Sex (% male) 2 76.1 1 56.8 - 61.8 2 82.1 - 86.8
Mean BMI Gly/Gly (range) 6 29.1 (17.8–61.6) 1 32.3 (23.0–42.2) 2 35.9 (33.1–40.7) - 37.2 (26.0–62.5) - 34.5 (26.3–44.2)
Mean BMI Gly/Ser (range) 9 29.3 (18.8–60.7) 3 33.0 (21.3–61.7) - 34.5 (21.4–66.7) 3 37.7 (22.2–93.4) - 36.5 (26.6–48.5)
Mean BMI Ser/Ser (range) - 29.7 (19.3–62.9) 3 34.2 (18.4–65.8) 1 36.5 (23.0–80.0) 1 36.7 (20.5–70.3) 1 36.8 (25.8–70.6)
Allele frequency rs8192678
Ser allele (Gout; Control)
2 0.346 (0.332; 0.371) 2 0.801 (0.803; 0.798) - 0.805 (0.782; 0.836) - 0.688 (0.698; 0.671) - 0.636 (0.651; 0.61)
Allele frequency rs8192678
Ser allele (Diabetes; Control)
2 0.346 (0.366; 0.345) 2 0.801 (0.788; 0.807) - 0.805 (0.847; 0.786) - 0.688 (0.703; 0.689) - 0.636 (0.667; 0.622)














values from the score distribution. The iHS normalisa-
tion conformed to a standard Gaussian distribution for
all populations. For XP-EHH, all pairwise comparisons
were performed between the groups of populations that
had been genotyped with genome-wide SNP arrays or
via WGS.
Fourteen combinations of populations and genes (corre-
sponding to six genes) previously reported by Voight et al.
[18] as showing evidence of selection were analysed as
positive controls to provide insight into the overall power
of detecting signatures of selection using the methods de-
scribed above (Additional file 1: Table S1).
Results
Association analyses
Tests for association between BMI and rs8192678 geno-
type did not reveal any statistically significant association
for any of the gene action models (Table 4). Similarly, no
relationship was observed between rs8192678 genotype
and either gout affection or T2D status, for any of the
modes of genetic action (Table 4). There were also no
statistically significant associations observed for the
meta-analysis of the Polynesian populations between
BMI, or gout affection, or T2D status and rs8192678
under any of the modes of genetic action.
Selection analyses
Intra-population tests for selection – Tajima’s D, Fay and
Wu’s H and iHS
Estimates of Tajima’s D and Fay and Wu’s H for windows
surrounding the Gly482Ser position, were within +/−
2.5% limits for all populations and window lengths
(Tables 5 and 6). Only the two Chinese populations
(CHB and CHS) had strong positive values for Tajima’s
D in the 1kbp region surrounding, suggesting possible
balancing selection, however estimates decayed to values
close to those of the chromosome average for the 30kbp
window size (Table 5), and were well within +/− 2.5%
thresholds. For Tajima’s D in 1 kb windows that over-
lapped the PPARGC1A-encoding region, all populations
had windows that exceeded both +2.5 and −2.5% thresh-
olds (Additional file 2: Figure S1c), but for the 5 kb
windows only the Māori population had windows ex-
ceeding the lower threshold (Additional file 2: Figure
S1b), indicating the possibility of a selective sweep. How-
ever, no population had any window in the PPARGC1A
genic region exceeding either threshold for the 30kbp re-
gion for Tajima’s D (Additional file 2: Figure S1a). More-
over, there did not appear to be a clear pattern within
any population that was consistent with a selective
sweep: estimates for the different window sizes were typ-
ically dispersed around the chromosome mean for each
population rather than showing a pattern where values
consistently exceeded the chromosome thresholds. Simi-
larly, for Fay and Wu’s H, no windows overlapping the
PPARGC1A region that exceeded +/− 2.5% thresholds
were observed with windows of 30 kbp (Additional file
3: Figure S2a). Only the Samoan population had a win-
dow that exceeded the threshold in the PPARGC1A
genic region for the 5 kb windows (Additional file 3:
Figure S2b). For the 1 kb windows, both the Māori and
Samoan populations had regions that exceeded lower
thresholds, indicating the possibility of an excess of high
frequency derived alleles (Additional file 3: Figure S2c).
However, for the region containing rs8192678, no win-
dow exceeded the +/− 2.5% thresholds in any popula-
tion, irrespective of window size (Table 6). Neither of
these site frequency spectra-based tests therefore re-
vealed evidence of selection in the regions containing
the Gly482Ser substitution.
We also calculated integrated haplotype homozygos-
ity score (iHS) statistics for rs8192678 for each
population using a genetic map. The iHS is a statistic
to detect evidence of recent positive selection at a
locus and is based on the differential levels of linkage
disequilibrium surrounding a positively selected allele
compared to the other allele at the same position.
Only the Samoan population had |iHS| > 3.29 when
computed using a genetic map (corresponding to the
most extreme 1% of |iHS| values) (Table 7, Fig. 1).
Plots of iHS +/− 1 Mbp of the PPARGC1A-encoding
region showed relatively few locations within this re-
gion that exceeded the 3.29 threshold in any of the
populations investigated (Fig. 1).
Table 3 Clinical and ancestral information for sample sets used in tests for selection analysis
obs missing (n) Māori AXIOM obs missing (n) Samoan OMNIexpress
Number - 71 - 96
Sex (% male) - 64.7 - 74
Gout cases (%) - 49.3 - 50.0
Mean BMI (range) 1 34.5 (22.1 to 56.1) - 36.1 (20.5 to 93.4)
Diabetes (%) 3 21.1 - 12.5
Mean grandparent ancestry (range) - 0.916 (0.625 to 1.00) - 0.997 (0.875 to 1.00)
Mean grandparent ancestry is the proportion of grandparents self-reported as belonging to the ethnicity group
BMI body mass index
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Table 4 Results from a single marker generalised linear model for rs8192678 and BMI, T2D and gout
Allele Freq (T) HWE Additive P value Dominant C (Gly) P value Dominant T (Ser) P value Heterozygous Advantage P value
Linear regression between BMI and rs8192678 under the 4 genetic models. Beta (95% CI)
NZ Caucasian 0.346 0.728 0.319 (−0.198, 0.835) 0.227 −0.555 (−1.618, 0.507) 0.305 0.350 (−0.358, 1.058) 0.332 0.102 (−0.601, 0.806) 0.775
NZ Māori 0.806 0.721 0.629 (−0.848, 2.106) 0.403 −0.837 (−2.588, 0.913) 0.347 0.263 (−3.885, 4.412) 0.901 −0.831 (−2.625, 0.964) 0.363
CI Māori 0.805 1.000 0.612 (−2.342, 3.566) 0.682 −0.627 (−3.940, 2.686) 0.709 1.319 (−8.733, 11.371) 0.795 −0.504 (−3.886, 2.879) 0.769
Samoan 0.688 0.043 −0.610 (−2.605, 1.386) 0.548 0.705 (−1.757, 3.166) 0.573 −0.873 (−5.749, 4.002) 0.724 0.487 (−1.989, 2.964) 0.698
Tongan 0.636 0.310 0.755 (−0.958, 2.468) 0.384 −0.895 (−3.382, 1.592) 0.477 1.336 (−2.118, 4.791) 0.445 −0.218 (−2.799, 2.363) 0.867
Polynesian 0.747 0.925 0.345 (−0.611, 1.300) 0.479 −0.408 (−1.587, 0.770) 0.496 0.470 (−1.904, 2.843) 0.698 −0.301 (−1.496, 0.895) 0.621
Logistic regression between gout affection and rs8192678. OR (95% CI)
NZ Caucasian 0.346 0.728 0.846 (0.683, 1.047) 0.125 1.290 (0.828, 1.996) 0.256 0.819 (0.612, 1.095) 0.180 0.916 (0.686, 1.221) 0.548
NZ Māori 0.806 0.721 1.238 (0.737, 2.111) 0.425 0.896 (0.488, 1.635) 0.721 3.644 (0.697, 28.949) 0.159 1.071 (0.578, 1.977) 0.827
CI Māori 0.805 1.000 0.785 (0.361, 1.654) 0.529 1.126 (0.488, 2.611) 0.780 - - 0.936 (0.397, 2.202) 0.879
Samoan 0.688 0.043 1.110 (0.638, 1.933) 0.711 1.097 (0.543, 2.220) 0.796 2.328 (0.658, 8.556) 0.189 1.437 (0.707, 2.975) 0.320
Tongan 0.636 0.310 1.073 (0.562, 2.039) 0.829 1.248 (0.477, 3.310) 0.651 1.911 (0.543, 6.737) 0.308 1.991 (0.713, 5.971) 0.199
Polynesian 0.747 0.925 1.149 (0.862, 1.533) 0.345 0.970 (0.678, 1.385) 0.865 2.024 (1.005, 4.126) 0.049 1.170 (0.814, 1.685) 0.396
Logistic regression between T2D and rs8192678. OR (95% CI)
NZ Caucasian 0.346 0.728 1.046 (0.767, 1.419) 0.774 0.953 (0.523, 1.835) 0.880 1.065 (0.700, 1.630) 0.771 1.041 (0.686, 1.576) 0.850
NZ Māori 0.806 0.721 0.768 (0.463, 1.294) 0.311 1.362 (0.737, 2.495) 0.319 0.706 (0.181, 3.535) 0.636 1.299 (0.692, 2.407) 0.409
CI Māori 0.805 1.000 2.280 (0.901, 6.410) 0.096 0.348 (0.111, 0.977) 0.054 0.647 (0.037, 20.494) 0.777 0.314 (0.095, 0.910) 0.042
Samoan 0.688 0.043 1.307 (0.630, 2.814) 0.480 0.788 (0.329, 1.886) 0.590 2.043 (0.316, 40.719) 0.527 0.904 (0.379, 2.142) 0.818
Tongan 0.636 0.310 1.063 (0.477, 2.443) 0.882 0.961 (0.328, 2.888) 0.942 1.198 (0.233, 9.316) 0.841 1.030 (0.342, 3.045) 0.957
Polynesian 0.747 0.925 1.738 (0.768, 4.219) 0.200 0.911 (0.610, 1.335) 0.646 1.104 (0.476, 2.901) 0.827 0.928 (0.617, 1.386) 0.716
The marker was assessed under an additive model, dominance models and heterozygous advantage model. Models are adjusted for gout and diabetes affection, sex, age and non –Caucasian ancestry. Estimate (95% CI). NZ =New
Zealand. CI = Cook Islands. Polynesian is a combination of NZ Māori, CI Māori, Samoan, and Tongan population groups. HWE= P-value for departure from Hardy Weinberg expectations using exact test, Logistic regression for CI Māori














We also evaluated six genes that had previously been re-
ported as exhibiting evidence of selection by Voight et al.
(2006) in specific ancestries. Here, there were 14 combina-
tions of genes and populations (Additional file 1: Table S1)
since two ancestries – Asian and Caucasian – were each
represented by two populations each in this study (CHS
and CHB for Asians, and CEU and GBR for Caucasians –
see Additional file 1: Table S1). Seven of the 14 gene-
population combinations showed evidence of selection in
the 1000 Genomes populations samples used for this
study (where we define evidence of selection as >1 SNP
exceeding the 1% threshold of iHS values, Additional file
1: Table S1). Overall, the analytical methods used in this
study detected evidence of selection at half of the loci pre-
viously shown to be under selection [18] that were tested.
Inter-population tests for selection - FST and XP-EHH
Population differentiation at rs8192678 was investigated
by calculating FST statistics for all pairwise combinations
all populations that had been genotyped with the Taq-
Man® assay. Derived allele frequencies from the WGS
and chip datasets were very similar to those found in
Myles et al. [4] with Polynesian (NZ Māori 0.83, Samoan
0.72), Asian (CHB 0.37, CHS 0.45), European (CEU 0.37,
GBR 0.33) and African (YRI 0.04). Results showed
strong differentiation between NZ Caucasian and all of
the Polynesian populations, with NZ Māori and
Caucasian being the most differentiated (0.332, Table 8).
Tongan and Samoan populations were less differentiated
from the NZ Caucasian population (0.160 and 0.210 re-
spectively). East – West Polynesia differentiation [23]
was also apparent, with FST between NZ Māori and
Samoan (0.033) and NZ Māori and Tongan (0.069) pop-
ulations greater than NZ Māori and CI Māori (0.000).
The Samoan and Tongan populations had relatively
small differentiation between them (FST = 0.003). Popula-
tion differentiation was also estimated for the Gly482Ser
variants in the genome-wide data sets (Table 9). For the
Gly482Ser substitution, Māori were more strongly differ-
entiated than the Samoan population from all of the
1000 Genomes populations, with strongest differenti-
ation occurring in the Yoruban population followed by
the European and Chinese populations. A similar but
less extreme trend was observed for the Samoan
Table 5 Tajima’s D at PPARGC1A calculated with window sizes of 1 kbp, 5 kbp, and 30 kbp
Tajima’s D 2.5% Quantile Chromosome Mean 97.5% Quantile
Tajima’s D value for 1 kb window containing rs8192678
CEU 0.810 −1.127 0.772 3.053
CHB 2.400 −0.835 1.068 3.199
CHS 2.566 −0.835 1.104 3.218
GBR 0.924 −1.091 0.817 3.068
YRI −0.445 −1.193 0.233 2.606
Māori −0.080 −1.083 0.886 2.996
Samoan 0.622 −1.119 0.943 3.103
Tajima’s D value for 5 kb window containing rs8192678
CEU 1.010 −1.358 1.089 3.805
CHB 1.729 −1.068 1.538 4.168
CHS 1.923 −1.054 1.599 4.204
GBR 1.846 −1.299 1.153 3.865
YRI −0.150 −1.486 0.310 2.892
Māori −1.040 −1.295 1.275 3.905
Samoan −0.235 −1.383 1.363 4.074
Tajima’s D value for 30 kb window containing rs8192678
CEU 1.480 −1.711 1.489 4.052
CHB 2.585 −1.265 2.102 4.730
CHS 2.267 −1.175 2.201 4.788
GBR 1.963 −1.571 1.567 4.185
YRI 0.029 −1.693 0.432 2.693
Māori −1.098 −1.463 1.732 4.416
Samoan −0.299 −1.698 1.857 4.616
Mean, 2.5% quantile and 97.5% quantile were calculated for chromosome 4 by population
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population: FST was highest for the Yoruban population,
with decreasing levels of differentiation between Euro-
pean and Chinese populations respectively. Lower FST
between Samoan and Caucasian populations compared
to the Māori and Caucasian populations was observed in
both the genome-wide genotyped populations and the
TaqMan®-genotyped populations.
We also calculated FST for 5Mbp windows surrounding
the Gly482Ser location to determine the (genomic) extent
of population differentiation (Table 10) over a wider win-
dow. Compared with the estimates at the rs8192678 locus
itself, 5Mbp window-based FST estimates were lower but
still revealed the same trend of most differentiation be-
tween the Polynesian and Yoruban populations, with
European populations the next most differentiated, and
Chinese populations the least differentiated (Table 9).
However, FST estimates between Māori and other
genome-wide genotyped populations differed little from
estimates between Samoan and other populations.
Cross population extended haplotype homozygosity
was calculated across chromosome 4 for all combina-
tions of populations that had been resequenced or geno-
typed genome-wide. There was no combination of
populations where XP-EHH estimates exceeded the
|3.29| threshold in the PPARGC1A region (Table 7).
Cross population extended haplotype homozygosity
values were also plotted across the aforementioned re-
gion by pairwise population combination (Fig. 1).
Table 6 Fay’s and Wu’s H at PPARGC1A calculated using window sizes of 1 kbp, 5 kbp, and 30 kbp
Fay and Wu’s H 2.5% Quantile Chromosome Mean 97.5% Quantile
Fay and Wu’s H 1 kb window containing rs8192678
CEU −0.094 −2.549 −0.168 0.710
CHB −0.106 −2.504 −0.174 0.691
CHS −0.007 −2.511 −0.173 0.693
GBR −0.227 −2.531 −0.162 0.713
YRI −1.132 −2.345 −0.055 0.888
Māori −0.845 −2.754 −0.217 0.648
Samoan −0.345 −2.884 −0.223 0.667
Fay and Wu’s H 5 kb window containing rs8192678
CEU −0.689 −8.467 −0.839 2.018
CHB −0.656 −8.237 −0.870 1.953
CHS −0.754 −8.133 −0.865 1.952
GBR −0.286 −8.309 −0.811 2.025
YRI 0.091 −7.300 −0.276 2.719
Māori −3.996 −9.132 −1.085 1.778
Samoan −2.342 −9.468 −1.117 1.859
Fay and Wu’s H 30 kb window containing rs8192678
CEU 2.955 −36.264 −5.032 7.377
CHB 3.675 −35.444 −5.221 7.381
CHS 2.617 −35.894 −5.187 7.302
GBR 3.433 −35.387 −4.867 7.472
YRI −1.989 −29.990 −1.657 10.606
Māori −14.842 −3.826 −6.509 6.379
Samoan −5.607 −41.697 −6.702 6.870
Mean, 2.5% quantile and 97.5% quantile were calculated for chromosome 4 by population
Table 7 iHS and XP-EHH statistics for rs8192678
CEU CHB CHS GBR YRI Māori Samoan
CEU −2.510a 0.548 0.163 0.321 1.319 −1.579 −0.771
CHB −0.548 −1.912a −1.578 −0.392 0.492 −2.695 −1.705
CHS −0.163 1.578 −1.775a −0.008 1.090 −2.226 −1.205
GBR −0.321 0.392 0.008 −2.074a 0.795 −1.752 −0.983
YRI −1.319 −0.492 −1.090 −0.795 -a −2.565 −1.754
Māori 1.579 2.695 2.226 1.752 2.565 −3.101a 1.163
Samoan 0.771 1.705 1.205 0.983 1.754 −1.163 −3.560a
All values are given as XP-EHH with the exception of those denoted by aindicating
integrated haplotype homozygosity scores (iHS). Rs8192678 had a derived allele
frequency < 0.05 in YRI and therefore iHS was not calculated
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Discussion and conclusions
The primary aim of this study was to directly test the
hypothesis that the PPARGC1A locus, in particular the
Gly482Ser substitution, has been subject to natural se-
lection in the progenitors of contemporary Polynesian
populations. The appropriate basis for concluding a
specific gene or region is subject to natural selection has
been defined by Vitti et al. [24] as ‘A combination of
genomic and functional evidence constitutes the current
standard for the field’. In this study we combined associ-
ation analyses between the Gly482Ser genotype and
traits either directly (BMI) or indirectly (gout and T2D,
which are correlated with BMI) to identify a potential
functional role of Gly482Ser. To identify genomic evi-
dence we used a recently-developed analytical pipeline
to test selection by a combination of site frequency spec-
tra based statistics, (Tajima’s D, Fay’s and Wu’s H) as well
as haplotype-length based measures that examine selec-
tion within populations (iHS) or between populations
(XP-EHH, [10]). We also estimated population differen-
tiation (FST), which has also been used as an indicator of
selection [25], as well as departure from expected HW
equilibrium. Of these various approaches, we were able
to detect departures from the expected neutral selection
model for FST only – no other statistics indicated con-
sistent functional or genomic evidence for selection.
However, reasons other than selection such as local co-
ancestry can lead to outlier values for FST [26] therefore
the FST results alone are not sufficient to conclude the
presence of selection.
Lack of evidence of selection in other statistical tests
may be a consequence of lack of power. In this regard,
two factors are important in interpreting results from
such analyses: (1) the nature of positive selection being
investigated, and (2) power of each of the statistical tests
to reject the null hypothesis of no departure from neu-
tral model of selection. Regarding (1), two intra-specific
selection scenarios were frequently examined: ‘hard
sweeps’ within populations based on selective advantages
Fig. 1 iHS/XP-EHH by Population. A +/− 1 Mb window centred on PPARGC1A.Threshold of |3.29| for both XP-EHH and iHS is marked with blue lines.
Location of PPARGC1A is marked in red for XP-EHH and light blue for iHS. Rs8192678 is indicated by the red dashed line. iHS (within population) is shown
on the diagonal. The arrowhead indicates the iHS value for rs8192678 in Samoans that exceeds the 1% threshold
Table 8 Single marker FST for rs8192678
NZ Caucasian NZ Māori CI Māori Samoan
NZ Māori 0.334 -
CI Māori 0.324 0.000 -
Samoan 0.205 0.035 0.032 -
Tongan 0.154 0.073 0.066 0.003
FST on the same populations was not calculated and negative FST was set to zero
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arising from a de novo mutation with strong positive ef-
fects on fitness, and ‘soft sweeps’ based on extant vari-
ants underpinning heritable characteristics that are
typically under polygenic control. Power (i.e., (2), above)
to detect evidence of selection for the various methods
used here differs depending upon these scenarios [27].
For the 482Ser allele investigated in this study, putative
selection could be either via hard or soft sweeps. On the
one hand, the previously reported absence of the derived
482Ser allele in some African and New Guinean popula-
tions [5] imply selection on a de novo mutation arising
prior to ancestors of modern Homo sapiens migrating
out Africa. On the other hand however, there is a relative
dearth of evidence of hard sweeps in humans [28]. In
addition, if PPARGC1A were indeed under selection, it
would have been subject to concomitant selection in mul-
tiple Polynesian and other populations (e.g., [29]) and act-
ing on extant variation at this locus. This suggests soft
sweeps are a more likely scenario, especially as Gly482Ser
is possibly one of very many small effect loci impacting
the T2D and correlated conditions such as BMI [30, 31].
Of the methods used in this study to directly examine
evidence of selection, none indicate selection has pos-
sibly occurred at this locus (Tables 4, 5, 6 and 7, and
Fig. 1). The power of Tajima’s D, Fay’s and Wu’s H, and
iHS to detect evidence of selection has recently been
evaluated by Ferrer-Admetlla et al. [27] for both hard
and soft sweeps. For Tajima’s D they reported variable
power across a wide range of selection coefficients, win-
dow sizes, and final (derived) allele frequencies for hard
sweeps. In hard sweeps where ending allele frequencies
were similar to those observed in Māori populations
(Table 4), moderate-high power was reported, but in soft
sweeps power was relatively low (<0.2). Even if such tests
are underpowered, the high number of populations,
some of which are from the same ancestry (i.e., CEU and
GBR being Caucasian, and CHB and CHS being Asian)
would likely have detected selection should a hard sweep
at this locus be occurring. Moreover, it is reasonable to
assume that if the 482Ser allele were a genuine thrifty
gene variant, selection would be occurring in all popula-
tions rather than being restricted to the Polynesian pop-
ulations, as most ancestral populations would have
experienced periodic limitations in food availability. For
iHS, Ferrer-Admetlla et al. [27] reported power was gen-
erally high (>0.75) irrespective of whether hard or soft
sweeps had occurred, and was similarly robust to differ-
ent ending allele frequencies – which ranged from 0.5 to
0.9. The derived 482Ser allele frequency estimates in all
of the Polynesian sample sets investigated in this study
fall within this range.
To provide further insights into whether or not the
lack of evidence of selection according to these statistics
was due to inadequate sample sizes, we also analysed 14
population/gene combinations that had previously been
identified as showing evidence of selection [18]. In our
population samples, seven of these 14 combinations had
>1 SNP exceeding the 1% iHS threshold, demonstrating
that our methods could identify loci previously shown to
be under selection (Additional file 1: Table S1). More-
over, in all of the seven cases, multiple SNPs exceeded
this threshold, and for two genes, there was evidence of
selection in both population samples representing the
same ancestry (i.e., evidence of selection in both CEU


















CEU 0.373 0.095 0.000 0.436 0.222 0.099 0.000 0.433
CHB 0.348 0.062 0.000 0.320 0.199 0.044 0.000 0.216
CHS 0.259 0.061 0.000 0.306 0.122 0.042 0.000 0.201
GBR 0.404 0.095 0.000 0.435 0.249 0.100 0.000 0.434
YRI 0.802 0.137 0.000 0.591 0.655 0.134 0.000 0.572


















CEU 0.094 0.094 0.068 0.120 0.084 0.098 0.070 0.133
CHB 0.069 0.061 0.038 0.088 0.050 0.044 0.027 0.067
CHS 0.067 0.060 0.035 0.090 0.047 0.042 0.025 0.067
GBR 0.088 0.094 0.067 0.124 0.082 0.099 0.070 0.133
YRI 0.145 0.138 0.106 0.178 0.142 0.136 0.098 0.188
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and GBR populations for LCT, and in both CHB and
CHS for SLC445A5, see Additional file 1: Table S1). This
indicates that population samples of this size have ap-
proximately 50% power to detect an association in the
1000 Genomes populations – none of which were case–
control studies - and that when selection is present,
there should be multiple SNPs exceeding the threshold.
Based on the above results, we therefore expect approxi-
mately (1–0.52) ≈ 0.75 probability of at least one of the
Samoan and Māori populations used in this study to
show evidence of selection using the iHS test. However
the (case–control) Samoan and Māori cohorts had (only)
one and zero SNPs, respectively, exceeding the 1% iHS
threshold. We also contend that, if anything, the use of a
case–control design would be more likely to increase the
frequency of haplotypes carrying the selected allele(s),
and thus more likely to improve power should this locus
be subject to selection. Therefore the lack of a statistically
significant difference in 482Ser allele frequencies in the case
control Māori cohort used in this study and the previously
reported estimate by Myles et al. [5] from a cross-sectional
study of a single Māori tribal group located in the East Coast
of the North Island of NZ, is further evidence of the lack of
evidence of natural selection at this locus.
A further consideration is the elevated derived 482Ser
allele frequency in all non-African populations compared
to the African populations [4, 5]. These show a progres-
sive differentiation of populations at this locus. Thus, if
PPARGC1A were a thrifty gene candidate that has been
subjected to natural selection, selection would likely
have occurred in all non-African ancestral populations
due to factors such as climatic extremes, competition
with other human groups, and/or the need to adapt to
newly colonised environments - all of which are likely to
contribute to periodic deprivations in food availability in
progenitors of all populations studied.
The highest derived allele frequencies and strongest
differentiation from extant African populations occurs in
the Cook Islands and NZ Māori populations. Therefore
if this locus is indeed a thrifty gene, recent migration
histories would suggest that these populations would be
likely to show evidence of association and/or selection
as ancestors of these populations colonised East
Polynesia less than 1500 years ago [32]. Thus we would
expect repeated evidence of selection at this locus in
most - if not all - of the populations examined. However,
the reverse is the case: there is no strong evidence of
positive selective at this locus according the iHS statistic,
nor Tajima’s D nor Fay and Wu’s H. Similarly, for the
NZ Māori population, evidence of possible differential
selection indicated by Tajima’s D in the PPARGC1A-en-
coding region exceeding the lower 97.5% quantile,
(Additional file 2: Figure S1a-c) was not reflected in ei-
ther Fay and Wu’s H (Additional file 3: Figure S2a-c) or
iHS (Fig. 1). Moreover, if selection on the derived 482Ser
allele were occurring then this would be revealed by XP-
EHH - for at least some population pairs. However, none
of the XP-EHH exceeded threshold 1% values in any of
the population pairs, nor were there any obvious differ-
ences in XP-EHH between pairs of populations that
share ancestry (i.e., the CEU – GBR pair, and the CHB –
CHS pair) compared to population pairs with different
ancestries. Further, differences in derived 482Ser allele
frequency within Polynesia – particularly those between
Western Polynesian (i.e., Tongan and Samoan) and Eastern
Polynesian (i.e., NZ and Cook Islands Māori) – are not ex-
plained by oceanic voyaging: the geographic distances be-
tween Tonga/Samoa and the Cook Islands is significantly
less than the Cook Islands and NZ, yet the Cook Islands
Māori 482Ser frequency differs from Samoa and Tonga and
is virtually identical to NZ Māori. These differences are also
reflected in the FST values (Table 8).
In addition, oral histories of Māori migrations make
no reference to extensive loss of life on vaka/waka due
to starvation during migration voyages [32], but do de-
scribe decisions by tribal groups, whose members were
generally closely related (e.g., [33]), to migrate due to
food competition and/or ongoing conflicts with other
tribal groups - effectively increasing the possibility of
genetic drift. We therefore conclude that the lack of evi-
dence for selection in any of the statistical tests used in
any of the populations examined in this study is likely
an accurate biological reflection for the populations ex-
amined rather than a lack of statistical power to detect
selective events at this locus with the methods used.
Existing 482Ser allele frequency distributions in the Pacific
can be explained by a combination of (a) migration out of
Africa by Homo sapiens progenitors and possibly
Denisovians who either lacked the 482Ser allele or lost it via
genetic drift (whose descendants include modern-day
Melanesians such as Papuans), (b) later migration out of
Africa by Homo sapiens progenitors of Polynesians subse-
quent to the mutation giving rise to the 482Ser allele, which
drifted to increasingly higher frequencies in repeated migra-
tions across the Pacific, and (c) followed by subsequent
admixture between these Melanesian progenitors with an-
cestors of modern Polynesians [34]. The higher derived al-
lele frequencies and genetic differentiation in Eastern
Polynesians are likely the result of genetic drift in the ances-
tral population, possibly as a result of founder effects. This
model is consistent with the absence of the 482Ser allele in
Denisovian DNA sequences; hence any derived populations
with Melanesian admixture – such as Tongan populations -
would have lower frequencies than in Eastern Polynesian
populations such as Cook Islands and NZ Māori. Genetic
drift therefore could account for the progressive increase in
allele frequency in modern non-African human populations,
with founder effects arising from successive colonisation of
Cadzow et al. BMC Medical Genetics  (2016) 17:80 Page 11 of 13
islands within Polynesia resulting in the increase in 482Ser
allele frequency.
Single marker regression analyses did not reveal any
evidence of association between rs8192678 and BMI,
gout affection status, or T2D in any of the populations
investigated. Although each Polynesian population was
small and likely to be underpowered for validating asso-
ciations between small effect genes and conditions, no
associations were found even when Polynesian popula-
tions were combined. We also found no evidence for
sex-specific effects for any of the three traits in the com-
bined Polynesian populations (data not shown). Our re-
sults contrast with those of Myles et al. [4] who reported
associations for Tongan populations (n = 184, P = 0.014–
0.037), but are consistent with the lack of association in
a NZ Māori tribe (Ngāti Rakaipaaka, n = 110, P > 0.8)
that was also reported by Myles et al. [4] as well as a
small Tongan population reported by Kimura et al. [14].
The results from these multiple studies when considered
together provide no repeated evidence for a functional
role of this locus for traits such as T2D, BMI or gout in
extant Māori or Samoan populations. However, it is pos-
sible that non-additive interaction with unmeasured envir-
onmental exposures may obscure evidence for main effect
association of Gly482Ser with metabolic phenotypes.
Based on the lack of evidence of association between
the Gly482Ser variant with BMI and correlated diseases,
as well as lack of evidence of association with any of the
tests for selection, we conclude that this study does not
support natural selection at either the Gly482Ser variant,
or the PPARGC1A region in general. More extreme fre-
quencies of the derived allele in the Polynesian popula-
tions can alternatively be explained by genetic drift
associated with ancestral population bottlenecks during
colonisation. Further, the lack of robust direct candidate
gene-based evidence for the thrifty gene hypothesis in
light of increasing evidence for selective influence of infec-
tious disease-causing agents on genome composition [35]
and other factors such as diet, responses to climate, and
skin colour collectively increase doubt regarding ongoing
validity of this hypothesis. This is supported by no global
of evidence for selection at 65 T2D loci with nominal evi-
dence for selection at individual loci driven by an equal
measure of T2D protective and risk haplotypes [31].
Additional files
Additional file 1: Table S1. Fourteen previously detected combinations of
populations and genes from Voight et al. (2006) were analysed using the
selscan software package (Szpiech and Hernandez 2014) as positive controls to
provide insight into possible power of detection of signatures of selection.
Seven of the previously detected 14 associations were repeated, where we
defined evidence of selection as >1 SNP exceeding the 5% threshold of iHS
values. For two genes (LCT in both CEU and GBR populations and SLC44A5 in
CHS and CHB populations) showed evidence of selection in populations with
similar ancestry (Caucasian and Asian, respectively). Evidence of selection for
one other gene (SNTG1) was observed in only one of two populations with the
same ethnicity. (DOCX 25 kb)
Additional file 2: Figures S1a-c. Tajima’s D calculated across
chromosome 4 using a 30 kbp sliding window by population. Chromosome
4:22.7–24.9 Mbp is shown with chromosome mean (blue) and 2.5%, 97.5%
quantiles (purple) from Table 4 marked. Location of PPARGC1A is marked in
red. Rs8192678 is marked by a red dashed line. Figure S1b Tajima’s D
calculated across chromosome 4 using a 5 kbp sliding window by
population. Chromosome 4:22.7–24.9 Mbp is shown with chromosome
mean (purple) and 2.5%, 97.5% quantiles (purple) from Table 4 marked.
Location of PPARGC1A is marked in red. Rs8192678 is marked by a red
dashed line. Figure S1c Tajima’s D calculated across chromosome 4 using a
1 kbp sliding window by population. Chromosome 4:22.7–24.9 Mbp is
shown with chromosome mean (blue) and 2.5%, 97.5% quantiles (purple)
from Table 4 marked. Location of PPARGC1A is marked in red. Rs8192678 is
marked by a red dashed line. (ZIP 1473 kb)
Additional file 3: Figures S2a-c. Fay and Wu’s H calculated across
chromosome 4 using a 30 kbp sliding window. Chromosome 4:22.7–24.9
Mbp is shown with chromosome mean (blue) and 2.5%, 97.5% quantiles
(purple) from Table 4 marked. Location of PPARGC1A is marked in red.
Rs8192678 is marked by a red dashed line. Figure S2b Fay and Wu’s H
calculated across chromosome 4 using a 5 kbp sliding window.
Chromosome 4:22.7–24.9 Mbp is shown with chromosome mean (blue)
and 2.5%, 97.5% quantiles (purple) from Table 4 marked. Location of
PPARGC1A is marked in red. Rs8192678 is marked by a red dashed line.
Figure S2c Fay and Wu’s H calculated across chromosome 4 using a 1
kbp sliding window. Chromosome 4:22.7–24.9 Mbp is shown with
chromosome mean (blue) and 2.5%, 97.5% quantiles (purple) from
Table 4 marked. Location of PPARGC1A is marked in red. Rs8192678 is
marked by a red dashed line. (ZIP 841 kb)
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